I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Biomimetic Responsive Nanoconverters with Immune Checkpoint..:
Yuting Zhang
;
Aoxue Zhong
;
Juan Min
...
doi:10.1021/acsami.3c18140.s001. , 1753
Link:
https://doi.org/10.1021/acsami.3c18140.s001
RT Journal T1
Biomimetic Responsive Nanoconverters with Immune Checkpoint Blockade Plus Antiangiogenesis for Advanced Hepatocellular Carcinoma Treatment
UL https://suche.suub.uni-bremen.de/peid=base-ftunivoxfordfig:oai:figshare.com:article_25135040&Exemplar=1&LAN=DE A1 Yuting Zhang A1 Aoxue Zhong A1 Juan Min A1 Haibin Tu A1 Yanbing Cao A1 Jinghao Fu A1 Yonghao Li A1 Xiaolong Liu A1 Yong Yang A1 Jianmin Wang A1 Jingfeng Liu A1 Ming Wu YR 1753 K1 Medicine K1 Genetics K1 Pharmacology K1 Biotechnology K1 Immunology K1 Cancer K1 Space Science K1 Biological Sciences not elsewhere classified K1 Chemical Sciences not elsewhere classified K1 sup >+</ sup K1 suboptimal response rates K1 strategy employed ph K1 prolong patient survival K1 plasma membrane derived K1 nanomedicine selectively accumulated K1 immune checkpoint inhibitor K1 angiogenesis inhibitor ) K1 agent smart nanomedicine K1 tumor side effects K1 advanced hepatocellular carcinoma K1 exert therapeutic effects K1 amphiphilic block copolymer K1 reduced immunosuppressive cells K1 immune effector cells K1 derived suppressor cells K1 large hcc occupying K1 tumor microenvironment revealed K1 biomimetic responsive nanoconverters K1 advanced hcc treatment K1 tumor microenvironment K1 advanced hcc K1 therapeutic schedule K1 responsive carriers K1 multifunctional nanoconverters K1 line treatment K1 block pd K1 regulatory cells K1 unfavorable pharmacodynamics K1 treated tumors K1 several limitations K1 liver volume K1 l1 ) K1 increased infiltration K1 findings highlight K1 effectively reshape K1 delivering apatinib K1 complete suppression K1 biocompatible manner K1 antiangiogenesis agents K1 amino esters JF doi:10.1021/acsami.3c18140.s001 LK http://dx.doi.org/https://doi.org/10.1021/acsami.3c18140.s001 DO https://doi.org/10.1021/acsami.3c18140.s001 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)